FDA approves Neos Therapeutics' long-acting ADHD drug

(Reuters) - Neos Therapeutics Inc's drug to treat a common type of childhood behavioral disorder was approved by the U.S. Food and Drug Administration, making it the first of its kind to win U.S. approval.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro